Detection technologies for identification of SARS-CoV-2 from environmental samples.
Twenty-seven (27) institutions responded to this Sprint call for innovations, including a range of non-traditional corporations, universities, government labs and other international solution providers. The innovations submitted in response to this largely focused on systems with direct collection capabilities and the separation of particles coupled with rapid target identification including detection of antigen, antibody, nucleic acid, or whole virus. Entries for this COVID-19 Detection Sprint were overwhelmingly prototype stage solutions, with options that addressed the entire pathway from collection to detection.
Highlights from the COVID-19 Detection Sprint response pool include:
To learn more about TechConnect Ventures' Innovation Sprints please contact Nick Kacsandi at
*Participation by any United States Federal Agency in any TechConnect activity or event does not constitute an expressed or implied endorsement of any cosponsor, donor, grantee, contractor or participant’s opinions, products, or services.